Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Multi-Regional Clinical Trials: The Latest Guidance From FDA
Conducting multi-regional clinical trials (MRCTs) is essential for accelerating oncology drug development and ensuring broader patient access. However, differences across regions can impact findings.
Pioneering Strategies For Early-Phase Oncology Trials
As the field advances, adaptive methodologies and regulatory shifts redefine early-phase oncology trials, promoting efficiency, flexibility, and equitable access.
Bridging The Trust Gap: How Patient Advocacy Groups Transforms Trial Recruitment
Explore how collaboration between researchers and Patient Advocacy Groups (PAGs) can bridge the trust gap that undermines recruitment and can make trial participation more approachable and meaningful.
Blueprints For Success: Strategic Protocols And Partnerships In Clinical Trials
By integrating patient feedback early in the design phase, trials can enhance recruitment and retention rates, ensuring both regulatory compliance and participant well-being.

In Search Of A Cure For Low Enrollment In Oncology Clinical Trials
10/19/2026

Delayed enrollment can cost oncology trials up to $250K per patient. Explore the barriers keeping patients out and practical ways to reach more of them faster.
Advancing Clinical Research In 2025: Meeting FDA Standards In DCT
1/22/2025

Explore the key components of new FDA guidance on DCTs, including a focus on participant-centric designs and the use of Mobile Research Units (MRUs) to overcome geographic and technological barriers.
Does 'The Belmont Report' Provide Guidance For Patient Stipends?
12/5/2025

Consider implementing fair and flexible stipend models that account for individual burdens to enhance diversity, equity, and participation in clinical trials.
Where Precision Drives Progress: Meeting The Rising Complexity Of Modern Clinical Trials
8/20/2026

Discover how leading teams are using trusted data and targeted AI to design, plan, and execute clinical trials with the confidence today's science requires.
Clinical Leader Smart Sourcing Solutions Expo: Mural Health Removing Barriers To Trial Participation
10/28/2025

Learn how one platform is transforming the participant journey to deliver a 60% reduction in participant drop-out and 97% engagement rates, improving retention for even the most vulnerable populations worldwide.

Purposed-Built For ADC Development

Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.
Balancing The Scales: The Strategic Role Of Stipends In Trial Success

Traditional clinical trial models can create financial burden by neglecting participant needs – but effective use of stipends can allow participants to fully engage without financial worries.
Patient Navigator Services For Complex Clinical Trials

Clinical trials often require travel coordination, reimbursements, and ongoing logistical support. Explore a service that centralizes those needs to help participants stay engaged.
Selecting The Right Pain Model For Early Phase Analgesic Trials

Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.
Advancing Lung Cancer Trials With Precision

Learn how specialized clinical expertise and global site networks accelerate complex trials. Streamline recruitment and advance novel therapies with proven operational solutions.